Pelthos Therapeutics PTHS Income Statement (2022-2026)

NYSE PTHS
$26.53 +0.69 (+2.67%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Revenue & cost
Revenue (Quarter) 0.29M16.50M26.51M
Cost of Revenue (Quarter) 2.32M1.67M5.28M
Gross Profit (Quarter) -2.02M14.83M21.23M
Operating items
Amortization - Intangibles (Quarter) 0.68M0.88M2.07M
Research & Development (Quarter) 0.19M0.05M0.05M2.29M0.47M0.01M0.41M0.28M0.19M0.51M0.14M0.37M0.79M
Selling, General & Administrative (Quarter) 0.48M0.54M0.66M1.06M0.79M1.21M1.63M1.54M1.09M1.11M19.63M18.47M48.78M
Other Operating Expenses (Quarter) 0.25M0.19M0.58M0.52M0.68M0.54M-1.61M4.64M0.55M1.61M3.00M2.55M7.36M
Operating Expenses (Quarter) 0.91M0.78M1.29M3.88M1.93M1.76M0.44M6.46M1.83M3.23M22.77M21.39M56.92M
Operating Income (Quarter) -0.91M-0.78M-1.29M-3.88M-1.93M-1.76M-2.05M-1.82M-1.83M-3.23M-15.36M-12.00M-30.41M
EBIT (Quarter) -0.91M-0.78M-1.29M-3.88M-1.93M-1.76M-2.05M-1.82M-1.83M-3.23M-15.36M-12.00M-30.41M
Non-operating items
Non Operating Income (Quarter) -0.05M-0.18M-0.13M-0.16M-0.63M-0.01M0.35M-0.10M-0.13M-0.22M-1.34M-16.58M-18.08M
Net income details
EBT (Quarter) -0.97M-0.95M-1.42M-4.04M-2.56M-1.77M-1.70M-1.93M-1.97M3.50M-16.70M-28.59M-48.49M
Tax Provisions (Quarter) -0.47M-6.92M
Profit After Tax (Quarter) -0.97M-0.95M-1.42M-4.04M-2.56M-1.77M-1.70M-1.93M-1.97M-3.45M-16.24M-21.66M-48.49M
Income from Continuing Operations (Quarter) -0.97M-0.95M-1.42M-4.04M-2.56M-1.77M-1.70M-1.93M-1.97M3.50M-16.24M-21.66M-48.49M
Consolidated Net Income (Quarter) -0.97M-0.95M-1.42M-4.04M-2.56M-1.77M-1.70M-1.93M-1.97M3.50M-16.24M-21.66M-48.49M
Income towards Parent Company (Quarter) -0.97M-0.95M-1.42M-4.04M-2.56M-1.77M-1.70M-1.93M-1.97M3.50M-16.24M-21.66M-48.49M
Net Income towards Common Stockholders (Quarter) -0.97M-0.95M-1.42M-4.04M-2.56M-1.77M-1.70M-1.93M-1.97M3.50M-16.24M-21.66M-48.49M
Additional items
EPS (Basic) (Quarter) -8.70-9.51-14.44-31.64-5.46-3.07-2.93-3.46-3.215.46-5.30-11.52-13.70
EPS (Diluted) (Quarter) -31.64-5.46-3.07-2.93-3.46-3.215.46-5.30-11.52-13.70
Shares Outstanding (Quarter) 0.04M0.11M0.10M0.10M0.13M0.47M0.58M0.58M0.56M0.61M0.64M3.06M1.88M3.54M
Shares Outstanding (Diluted) (Quarter) 0.13M0.47M0.58M0.58M0.56M0.61M0.64M3.06M1.88M3.54M
Shares Outstanding (Entity) (Quarter) 0.04M0.11M0.10M0.10M0.13M0.47M0.58M0.58M0.61M0.62M0.67M3.09M1.88M3.83M
EBITDA (Quarter) -0.91M-0.78M-1.29M-3.88M-1.93M-1.76M-2.05M-1.82M-1.83M-3.23M-15.36M-12.00M-30.41M
Interest Expenses (Quarter) 1.86M0.03M0.09M0.04M0.36M0.36M0.36M0.11M0.01M0.10M1.58M-1.37M4.74M
Tax Rate (Quarter) 2.78%24.21%